New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Mark Cuban: A Master Disrupter for American Health...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
High-speed imaging tracks live brain cell activity...
World is falling behind on UN's child mortality Sustainable ...
April 16,2026
Health literacy initiative improves discharge education, rea...
April 15,2026
Constipation is common, but with simple changes, you can man...
April 14,2026
Children and teenagers more open to meat free diets—but stru...
April 13,2026
3D-printed ATLAS platform helps model cancer cell clusters b...
April 12,2026
3 million-cell map shows menopause reshapes breast tissue, p...
April 11,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Today's News
Why is Alzheimer’s disease so difficult to treat? ...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Proteomic profile study reveals signatures for distinguishing different forms of Alzheimer's disease

Proteomic profile study reveals signatures for distinguishing different forms of Alzheimer's disease

by Justin Jackson , Medical XpressCredit: Pixabay/CC0 Public DomainResearchers at Washington University School of Medicine in St. Louis have identified proteomic changes associated with forms of Alzhe
Neurology May 20,2024
Proteomic profile study reveals signatures for distinguishing different forms of Alzheimer's disease

Proteomic profile study reveals signatures for distinguishing different forms of Alzheimer's disease

by Justin Jackson , Medical XpressCredit: Pixabay/CC0 Public DomainResearchers at Washington University School of Medicine in St. Louis have identified proteomic changes associated with forms of Alzhe
Neurology May 20,2024
Big data initiative discovers new causal pathways in Alzheimer's

Big data initiative discovers new causal pathways in Alzheimer's

by King's College LondonFlowchart of study design. CTL, cognitively normal controls; MCI, mild cognitive impairment; AD, Alzheimer's disease; Aβ, β-amyloid; CSF, cerebrospinal fluid; A, a
Neurology May 20,2024
Big data initiative discovers new causal pathways in Alzheimer's

Big data initiative discovers new causal pathways in Alzheimer's

by King's College LondonFlowchart of study design. CTL, cognitively normal controls; MCI, mild cognitive impairment; AD, Alzheimer's disease; Aβ, β-amyloid; CSF, cerebrospinal fluid; A, a
Neurology May 20,2024
Treatment of metabolic dysfunction could be a potential therapy for Alzheimer's disease

Treatment of metabolic dysfunction could be a potential therapy for Alzheimer's disease

by Yale-NUS CollegeCredit: CC0 Public DomainA team of researchers led by Yale-NUS College has found evidence that metabolic dysfunction is a primary cause of Alzheimer's disease.Alzheimer&#39
Neurology May 20,2024
Treatment of metabolic dysfunction could be a potential therapy for Alzheimer's disease

Treatment of metabolic dysfunction could be a potential therapy for Alzheimer's disease

by Yale-NUS CollegeCredit: CC0 Public DomainA team of researchers led by Yale-NUS College has found evidence that metabolic dysfunction is a primary cause of Alzheimer's disease.Alzheimer&#39
Neurology May 20,2024
Single brain scan can diagnose Alzheimer's disease

Single brain scan can diagnose Alzheimer's disease

by Imperial College LondonPET scan of a human brain with Alzheimer's disease. Credit: public domainThe research uses machine learning technology to look at structural features within the brai
Neurology May 20,2024
Single brain scan can diagnose Alzheimer's disease

Single brain scan can diagnose Alzheimer's disease

by Imperial College LondonPET scan of a human brain with Alzheimer's disease. Credit: public domainThe research uses machine learning technology to look at structural features within the brai
Neurology May 20,2024
Single dual time-point PET scan identifies dual Alzheimer's biomarkers

Single dual time-point PET scan identifies dual Alzheimer's biomarkers

by Society of Nuclear MedicineWhile subject #1 (left) was judged as positive for both the neuronal injury and the amyloid load biomarker, both Alzheimer's disease biomarkers were negative in
Neurology May 20,2024
Single dual time-point PET scan identifies dual Alzheimer's biomarkers

Single dual time-point PET scan identifies dual Alzheimer's biomarkers

by Society of Nuclear MedicineWhile subject #1 (left) was judged as positive for both the neuronal injury and the amyloid load biomarker, both Alzheimer's disease biomarkers were negative in
Neurology May 20,2024
Approximately half of AD dementia cases are mild, one-fifth are severe

Approximately half of AD dementia cases are mild, one-fifth are severe

by Boston University School of MedicineCredit: CC0 Public DomainWhat percent of patients with Alzheimer's Disease (AD) currently have severe dementia? Do more people have mild disease? Or are
Neurology May 20,2024
Approximately half of AD dementia cases are mild, one-fifth are severe

Approximately half of AD dementia cases are mild, one-fifth are severe

by Boston University School of MedicineCredit: CC0 Public DomainWhat percent of patients with Alzheimer's Disease (AD) currently have severe dementia? Do more people have mild disease? Or are
Neurology May 20,2024
Big data reveals new Alzheimer's risk genes

Big data reveals new Alzheimer's risk genes

by University of EdinburghPET scan of a human brain with Alzheimer's disease. Credit: public domainAn international research team led by scientists at the University of Edinburgh and the Univ
Neurology May 20,2024
Big data reveals new Alzheimer's risk genes

Big data reveals new Alzheimer's risk genes

by University of EdinburghPET scan of a human brain with Alzheimer's disease. Credit: public domainAn international research team led by scientists at the University of Edinburgh and the Univ
Neurology May 20,2024
Does shingles increase a person's risk of dementia?

Does shingles increase a person's risk of dementia?

by American Academy of NeurologyCredit: CC0 Public DomainShingles, a viral infection caused by the reactivation of the chickenpox virus, results in a painful blistering rash along one side of the
Neurology May 20,2024
Does shingles increase a person's risk of dementia?

Does shingles increase a person's risk of dementia?

by American Academy of NeurologyCredit: CC0 Public DomainShingles, a viral infection caused by the reactivation of the chickenpox virus, results in a painful blistering rash along one side of the
Neurology May 20,2024
Protein misfolding as a risk marker for Alzheimer's disease

Protein misfolding as a risk marker for Alzheimer's disease

by German Cancer Research CenterCredit: CC0 Public DomainIn symptom-free individuals, the detection of misfolded amyloid-β protein in the blood indicates a considerably higher risk of Alzheimer&#
Neurology May 20,2024
Protein misfolding as a risk marker for Alzheimer's disease

Protein misfolding as a risk marker for Alzheimer's disease

by German Cancer Research CenterCredit: CC0 Public DomainIn symptom-free individuals, the detection of misfolded amyloid-β protein in the blood indicates a considerably higher risk of Alzheimer&#
Neurology May 20,2024
Can Mediterranean diet help people with MS preserve thinking skills?

Can Mediterranean diet help people with MS preserve thinking skills?

by American Academy of NeurologyCredit: Pixabay/CC0 Public DomainPeople with multiple sclerosis (MS) who follow a Mediterranean diet may have a lower risk for problems with memory and thinking sk
Neurology May 20,2024
Can Mediterranean diet help people with MS preserve thinking skills?

Can Mediterranean diet help people with MS preserve thinking skills?

by American Academy of NeurologyCredit: Pixabay/CC0 Public DomainPeople with multiple sclerosis (MS) who follow a Mediterranean diet may have a lower risk for problems with memory and thinking sk
Neurology May 20,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu... ... Eye Infections (Updated) | Clinical Medicine ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com